Indian Journal of Nuclear Medicine
Home | About IJNM | Search | Current Issue | Past Issues | Instructions | Ahead of Print | Online submissionLogin 
Indian Journal of Nuclear Medicine
  Editorial Board | Subscribe | Advertise | Contact
Users Online: 540 Print this page  Email this page Small font size Default font size Increase font size
This article has been cited by
1Integrin avß3 as a Promising Target to Image Neoangiogenesis Using In-House Generator-Produced Positron Emitter 68Ga-Labeled DOTA-Arginine-Glycine-Aspartic Acid (RGD) Ligand
Rakhee Vatsa,Priya Bhusari,Sunil Kumar,Sudipta Chakraborty,Ashutosh Dash,Gurpreet Singh,Devinder Kumar Dhawan,Jaya Shukla,Bhagwant Rai Mittal
Cancer Biotherapy and Radiopharmaceuticals.2015;30(5)217
2An improved kit formulation for one-pot synthesis of [99m Tc]Tc-HYNIC-E[c(RGDfK)]2 for routine clinical use in cancer imaging
Sudipta Chakraborty,Soumen Das,Rubel Chakravarty,Haladhar Dev Sarma,Rakhee Vatsa,Jaya Shukla,Bhagwant Rai Mittal,Ashutosh Dash
Journal of Labelled Compounds and Radiopharmaceuticals.2019;62(12)823
3Evaluating the potential of kit-based 68Ga-ubiquicidin formulation in diagnosis of infection
Priya Bhusari,Jyotsna Bhatt,Apurva Sood,Ruchikapreet Kaur,Rakhee Vatsa,Ashu Rastogi,Archana Mukherjee,Ashutosh Dash,Bhagwant Rai Mittal,Jaya Shukla
Nuclear Medicine Communications.2019;40(3)228
4Toward realization of ‘mix-and-use’ approach in 68 Ga radiopharmacy: preparation, evaluation and preliminary clinical utilization of 68 Ga-labeled NODAGA-coupled RGD peptide derivative
Sudipta Chakraborty,Rubel Chakravarty,Rakhee Vatsa,Priya Bhusari,H.D. Sarma,Jaya Shukla,B.R. Mittal,Ashutosh Dash
Nuclear Medicine and Biology.2016;43(1)116
5Detailed evaluation of different68Ge/68Ga generators: an attempt toward achieving efficient68Ga radiopharmacy
Rubel Chakravarty,Sudipta Chakraborty,Ramu Ram,Rakhee Vatsa,Priya Bhusari,Jaya Shukla,B. R. Mittal,Ashutosh Dash
Journal of Labelled Compounds and Radiopharmaceuticals.2016;59(3)87
6An electroamalgamation approach to separate 47Sc from neutron-activated 46Ca target for use in cancer theranostics
Rubel Chakravarty,Sudipta Chakraborty,Ramu Ram,Ashutosh Dash
Separation Science and Technology.2017;52(14)2363
7Trans-kinetic effects in ligand substitution processes of ruthenium polypyridyl complexes
Juan H. Mecchia Ortiz,Analia M. Peyrot,Florencia Fagalde,Néstor E. Katz
Inorganic Chemistry Communications.2018;98(14)44
8Clinical 68Ga-PET: Is radiosynthesis module an absolute necessity?
Rubel Chakravarty,Sudipta Chakraborty,ER Radhakrishnan,Koramadai Kamaleshwaran,Ajit Shinto,Ashutosh Dash
Nuclear Medicine and Biology.2017;46(14)1
9Development of Lu-177-trastuzumab for radioimmunotherapy of HER2 expressing breast cancer and its feasibility assessment in breast cancer patients
Priya Bhusari,Rakhee Vatsa,Gurpreet Singh,Madan Parmar,Amanjit Bal,Devinder K. Dhawan,Bhagwant R. Mittal,Jaya Shukla
International Journal of Cancer.2017;140(4)938
10Development and characterization of DTPA-trastuzumab conjugates for radiolabeling with Tc-99m: A radiopharmaceutical for HER2/neu breast cancer
Priya Bhusari,Rakhee Vatsa,Gurpreet Singh,Devinder K. Dhawan,Jaya Shukla,Bhagwant R. Mittal
Journal of Drug Delivery Science and Technology.2015;29(4)8
11Clinically Relevant Radioactive Dose Formulation of 177 Lu-Labeled Cetuximab-Fab Fragment for Potential Use in Cancer Theranostics
Rubel Chakravarty,Nanda Rohra,Sudipta Chakraborty,Ratnesh Jain,Haladhar Dev Sarma,Ashutosh Dash
12Facile One-Pot Synthesis of Intrinsically Radiolabeled 64 Cu-Human Serum Albumin Nanocomposite for Cancer Targeting
Rubel Chakravarty,Sudipta Chakraborty,Apurav Guleria,Amit Kunwar,Haladhar Dev Sarma,Ashutosh Dash
1390Y/177Lu-labelled Cetuximab immunoconjugates: radiochemistry optimization to clinical dose formulation
Rubel Chakravarty,Sudipta Chakraborty,Haladhar Dev Sarma,K. V. Vimalnath Nair,Ardhi Rajeswari,Ashutosh Dash
Journal of Labelled Compounds and Radiopharmaceuticals.2016;59(9)354

Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal